Silymarin and Its Role in Chronic Diseases

被引：37
作者：
Neha [1 ]
Jaggi, Amteshwar S. [1 ]
Singh, Nirmal [1 ]
机构：
[1] Punjabi Univ, Fac Med, Dept Pharmaceut Sci & Drug Res, Pharmacol Div, Patiala 147002, Punjab, India
来源：
DRUG DISCOVERY FROM MOTHER NATURE | 2016年 / 929卷
关键词：
Silybum marianum; Silymarin; Silybin; Isosilybin; Hepatitis; Cancer; Oxidative stress; Immunomodulation; NF-KAPPA-B; PROSTATE-CANCER PREVENTION; FLAVONOIDS BIOCHANIN-A; MILK THISTLE; SILYBUM-MARIANUM; OXIDATIVE STRESS; BETA-CATENIN; INDUCED APOPTOSIS; VIRAL-HEPATITIS; LIVER-DISEASE;
D O I：
10.1007/978-3-319-41342-6_2
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Silymarin is the active constituent of Silybum marianum (milk thistle) which is a C-25 containing flavonolignan. Milk thistle has a lot of traditional values, being used as a vegetable, as salad, as bitter tonic, and as galactogogue in nursing mothers and in various ailments such as liver complications, depression, dyspepsia, spleenic congestions, varicose veins, diabetes, amenorrhea, uterine hemorrhage, and menstrual problems. In this present chapter, a comprehensive attempt has been made to discuss the potential of silymarin in chronic disorders. An insight into modulation of cellular signaling by silymarin and its implication in various disorders such as liver disorders, inflammatory disorders, cancer, neurological disorders, skin diseases, and hypercholesterolemia is being provided.
引用
收藏
页码：25 / 44
页数：20
相关论文
共 100 条
[81]   Silymarin induces recovery of pancreatic function after alloxan damage in rats [J].
Soto, C ;
Mena, R ;
Luna, J ;
Cerbón, M ;
Larrieta, E ;
Vital, P ;
Uría, E ;
Sánchez, M ;
Recoba, R ;
Barrón, H ;
Favari, L ;
Larag, A .
LIFE SCIENCES, 2004, 75 (18) :2167-2180
[82]   Effect of silymarin on kidneys of rats suffering from alloxan-induced diabetes mellitus [J].
Soto, C. ;
Perez, J. ;
Garcia, V. ;
Uria, E. ;
Vadillo, M. ;
Raya, L. .
PHYTOMEDICINE, 2010, 17 (14) :1090-1094
[83]   Prevention of alloxan-induced diabetes mellitus in the rat by silymarin [J].
Soto, CP ;
Perez, BL ;
Favari, LP ;
Reyes, JL .
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-PHARMACOLOGY TOXICOLOGY & ENDOCRINOLOGY, 1998, 119 (02) :125-129
[84]  
Strazzabosco, 1999, J HEPATOL, V12, P290
[85]   Silibinin causes cell cycle arrest and apoptosis in human bladder transitional cell carcinoma cells by regulating CDKI-CDK-cyclin cascade, and caspase 3 and PARP cleavages [J].
Tyagi, A ;
Agarwal, C ;
Harrison, G ;
Glode, LM ;
Agarwal, R .
CARCINOGENESIS, 2004, 25 (09) :1711-1720
[86]  
Tyagi A, 2002, MOL CANCER THER, V1, P525
[87]   Hepatoprotective effect of silymarin [J].
Vargas-Mendoza, Nancy ;
Madrigal-Santillan, Eduardo ;
Morales-Gonzalez, Angel ;
Esquivel-Soto, Jaime ;
Esquivel-Chirino, Cesar ;
Garcia-Luna y Gonzalez-Rubio, Manuel ;
Gayosso-de-Lucio, Juan A. ;
Morales-Gonzalez, Jose A. .
WORLD JOURNAL OF HEPATOLOGY, 2014, 6 (03) :144-149
[88]   Silibinin efficacy against human hepatocellular carcinoma [J].
Varghese, L ;
Agarwal, C ;
Tyagi, A ;
Singh, RP ;
Agarwal, R .
CLINICAL CANCER RESEARCH, 2005, 11 (23) :8441-8448
[89]   Long-term (12 months) treatment with an anti-oxidant drug (silymarin) is effective on hyperinsulinemia, exogenous insulin need and malondialdehyde levels in cirrhotic diabetic patients [J].
Velussi, M ;
Cernigoi, AM ;
DeMonte, A ;
Dapas, F ;
Caffau, C ;
Zilli, M .
JOURNAL OF HEPATOLOGY, 1997, 26 (04) :871-879
[90]   THE ROLE OF FREE-RADICALS IN THE PATHOGENESIS OF AMIODARONE TOXICITY [J].
VERECKEI, A ;
BLAZOVICS, A ;
GYORGY, I ;
FEHER, E ;
TOTH, M ;
SZENASI, G ;
ZSINKA, A ;
FOLDIAK, G ;
FEHER, J .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 1993, 4 (02) :161-177
12345678910